Precision, speed, impact: Evolving mass spectrometry for med...

MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.

Looking to early-stage companies for innovation, with Juerge...

In an interview at BIO 2025, Bayer's Juergen Eckhardt discusses the importance of external innovation and why his company is prioritising early stage.

Going wide on immune system activation, with Jeffrey Meckler

Indaptus CEO Jeff Meckler discusses his company's unconventional approach to immunotherapy, based on activating a wide swath of the immune system.

BIO 2025: Healey shades Trump as she announces $40M in tax i...

Massachusetts Governor Maura Healey took shots at the Trump Administration as she announced $40M in life sciences tax incentives at BIO 2025.

Transforming drug development with statistical methodologies

The product development lifecycle is long and challenging.

Where innovation meets collaboration: Live from Manchester’s...